Clinical-immunological Features of DNER Ataxia (CLIMDA)

Civil Hospices of Lyon

Status: Unknown

Conditions: DNER Ataxia

Treatments: Genetic: Description of clinical characteristic and genetic tumors

Study type: Observational

Funder types: Other

Identifiers

NCT05225896

497

Details and patient eligibility

About

Using a retrospective cohort of 34 patients with DNER ataxia, we will characterize clinical presentation, tumor associations, and outcomes.

Enrollment: 34 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient > 18 years old
• Patient with neurological disorder
• Patient with DNER antibodies in sera or CSF

Exclusion criteria

• • No available clinical data
• Patient without DNER antibodies or neurological disorder

Trial design

34 participants in 1 patient group

DNER ataxia

Description:

Patients with well-characterized DNER antibodies.

Treatment:

Genetic: Description of clinical characteristic and genetic tumors